Sign Up to like & get
recommendations!
0
Published in 2021 at "Cancer Research"
DOI: 10.1158/1538-7445.sabcs20-ps5-09
Abstract: BACKGROUND The molecular breast cancer subgroups comprise diverse immune biology; for human epidermal growth factor receptor 2-positive (HER2+) breast cancer (BC) and triple-negative breast cancer (TNBC) abundance of tumour infiltrating lymphocytes (TILs) have been shown…
read more here.
Keywords:
tamoxifen benefit;
premenopausal patients;
cancer;
breast cancer ... See more keywords